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Conditionally reprogrammed 
primary airway epithelial cells 
maintain morphology, lineage 
and disease specific functional 
characteristics
Kelly M. Martinovich1, Thomas Iosifidis  2,3, Alysia G. Buckley4, Kevin Looi  1, Kak-Ming 
Ling1, Erika N. Sutanto1, Elizabeth Kicic-Starcevich1, Luke W. Garratt  1, Nicole C. Shaw1, 
Samuel Montgomery1, Francis J. Lannigan2, Darryl A. Knight5,6,7, Anthony Kicic  1,2,3,8,9 & 
Stephen M. Stick1,2,3,8
Current limitations to primary cell expansion led us to test whether airway epithelial cells derived 
from healthy children and those with asthma and cystic fibrosis (CF), co-cultured with an irradiated 
fibroblast feeder cell in F-medium containing 10 µM ROCK inhibitor could maintain their lineage 
during expansion and whether this is influenced by underlying disease status. Here, we show that 
conditionally reprogrammed airway epithelial cells (CRAECs) can be established from both healthy and 
diseased phenotypes. CRAECs can be expanded, cryopreserved and maintain phenotypes over at least 
5 passages. Population doublings of CRAEC cultures were significantly greater than standard cultures, 
but maintained their lineage characteristics. CRAECs from all phenotypes were also capable of fully 
differentiating at air-liquid interface (ALI) and maintained disease specific characteristics including; 
defective CFTR channel function cultures and the inability to repair wounds. Our findings indicate that 
CRAECs derived from children maintain lineage, phenotypic and importantly disease-specific functional 
characteristics over a specified passage range.
The study of the respiratory epithelium is critical to many chronic lung diseases such as cystic fibrosis (CF) and 
asthma. Work by us and others, suggests a dynamic and critical role of primary airway epithelial cells (pAEC) 
in the pathogenesis of chronic lung diseases1–5. Until recently, the difficulty in obtaining target organ tissue from 
patients, specifically in children, has meant that most information regarding these diseases has been derived from 
studies performed in immortalised cell lines, animal models or tissue from adults6–8. We and others have success-
fully adapted, implemented and optimised a method to obtain airway epithelial cells (AEC) by airway brushing 
in children1,9–11 providing a primary cell source which subsequently has been used to establish cultures for the 
study of paediatric lung diseases.
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There are, however several limitations in primary AEC culture establishment. Firstly, cell yields and viabil-
ity from airway brushings are highly variable. Secondly, primary cell cultures take 10–14 days to fully establish 
before being expanded via serial passage1. Finally, primary cells have a very limited proliferative capacity in vitro, 
undergoing approximately 3–4 population doublings before becoming senescent1. Ideally, cultures should be suc-
cessfully established from every brushing irrespective of disease phenotype, have greater proliferative capacity to 
enable expansion beyond current limits and allow for multiple downstream experiments using matched samples. 
Critically, these cultures should maintain their epithelial lineage and phenotypic characteristics. Here, we describe 
such a methodology utilising defined additives and feeder cell layer.
The concept of co-culturing multiple cell types together to improve proliferation is relative commonplace12,13. 
Fibroblast-epithelial co-culture models include those from the nose14,15, cornea16, particular tumours17,18 and 
skin keratinocytes19. However, this cell co-culture method has not yet been applied for hard to obtain tissues, 
including pAECs from children. Cell co-culture systems commonly utilise the murine embryonic fibroblast cell 
line, NIH-3T3 as an irradiated feeder cell layer as well as a Rho-associated kinase (ROCK) inhibitor that has been 
shown to increase population doublings and proliferation of prostate and breast epithelial cells while retaining 
original karyotypes20–22. We have chosen here to use these two conditions to assess their effect on primary pae-
diatric AEC cultures which we term conditionally reprogrammed airway epithelial cells (CRAECs). We were 
particularly interested to determine whether these culture conditions preserved the phenotypic and functional 
abnormalities seen in cells from children with asthma or CF.
In this study, we tested the hypothesis that cell morphology, epithelial mRNA and protein expression profiles as 
well as functional changes of AEC grown under co-culture conditions are maintained while the population dou-
bling capacity and cell yield is significantly improved compared to our standard culture method. Results generated 
in this study, show that co-culturing AECs with irradiated NIH-3T3 fibroblast cells and in the presence of a ROCK 
inhibitor significantly improves pAEC growth rates and extends the number of population doublings in vitro. This 
methodology significantly increases the total number of cells available for experimental purposes whilst retaining 
epithelial lineage characteristics and disease specific abnormal functionalities over a specified passage range.
Results
Cell Culture improvements. CRAECs exhibited a characteristic epithelial cobblestone morphology which was 
maintained throughout the life of every culture. There were no observed morphological differences between healthy 
(Fig. 1a & b), asthmatic (Fig. 1c & d) and CF (Fig. 1e & f) cultures over passages 1 to 5. Conditional reprogramming 
of pAEC cultures improved the population doubling times of both the healthy and disease phenotypes compared to 
standard cultures for healthy (CRAEC slope 0.56 ± 0.02, pAEC 0.08 ± 0.01; p = 0.0001; Fig. 2a), asthmatic (CRAEC 
slope 0.41 ± 0.03, pAEC 0.06 ± 0.02; p = 0.0048 Fig. 2b) and CF cultures (CRAEC slope 0.50 ± 0.01, pAEC 0.06 ± 0.02; 
p = 0.0001; Fig. 2c). When assessed over time, population doubling rates of cultures at passage 1 were not significantly 
different between healthy (5.10 ± 0.26) and CF (4.51 ± 0.06) (p = 0.0702), however were between heathy and asthmatic 
phenotypes (4.23 ± 0.22) (p = 0.0464). No significant difference was seen between asthmatic and CF phenotypes at this 
passage (p = 0.2856). When doubling rates were assessed at passage 5, no significant differences were observed between 
any of the phenotypes (healthy 3.64 ± 0.36, Asthmatic 3.90 ± 0.47, CF 4.10 ± 0.406).
Figure 1. Epithelial cobblestone morphology is maintained over passage. (a) Healthy CRAEC monolayer at 
confluence, passage one. (b) Healthy CRAEC monolayer at confluence, passage five. (c) Asthmatic CRAEC 
monolayer at confluence, passage one. (d) Asthmatic CRAEC monolayer at confluence, passage five. (e) Cystic 
fibrosis CRAEC monolayer at confluence, passage one. (f) Cystic fibrosis CRAEC monolayer at confluence, 
passage five. Representative image of n = 4 patients per phenotype/passage. Scale bar: 100 µm.
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Cell yields were also significantly improved with conditional reprogramming; healthy (CRAEC 
108.20 ± 50.63 × 103 cells/cm2 vs pAEC 28.60 ± 10.54 × 103 cells/cm2, p = 0.0001; Fig. 3a), asthmatic (CRAEC 
97.80 ± 44.68 × 103 cells/cm2 vs pAEC 33.43 ± 13.36 × 103 cells/cm2, p = 0.0001; Fig. 3b) and CF (CRAEC 
108.10 ± 45.40 × 103 cells/cm2 vs pAEC 36.86 ± 15.97 × 103 cells/cm2, p = 0.0001 Fig. 3c). The improved cell yield 
facilitated routine cryopreservation of all cultures and improved their recovery capacity. After at least 1 month 
in liquid nitrogen storage, CRAECs of various passages were thawed. High cell viabilities were achieved for each 
phenotype recovered; healthy (75.77% ± 8.62%), asthmatic (88.50% ± 5.07%) and CF (83.79% ± 10.20%).
Epithelial lineage is maintained. Maintenance of epithelial lineage over passage was confirmed via two 
methods; qPCR and immunocytochemistry. No statistical differences were found for CK19, CK5 or VIM gene 
expression between passage one and five for all three phenotypes (Fig. 4). Expression of epithelial gene CK19 
was significantly higher than that the mesenchymal marker VIM in all three phenotypes; healthy (p1: CK19 
2.53 ± 0.67 VIM 0.05 ± 0.02 p = 0.01; p5: CK19 2.89 ± 1.20 VIM 0.22 ± 0.19 p = 0.02; Fig. 4a) asthmatic (p1: CK19 
1.88 ± 0.71 VIM 0.02 ± 0.02 p = 0.01; p5: CK19 2.57 ± 0.36 VIM 0.06 ± 0.05 p = 0.01; Fig. 4b) and CF (p1: CK19 
3.52 ± 1.12 VIM 0.04 ± 0.04 p = 0.01; p5: CK19 2.47 ± 1.09 VIM 0.12 ± 0.08 p = 0.01; Fig. 4c). CK5 expression was 
also significantly higher than VIM expression and maintained over extended passage and between all phenotypic 
groups (p1: CK5 0.57 ± 0.33 VIM 0.05 ± 0.02 p = 0.02, p5: CK5 0.42 ± 0.34 VIM 0.22 ± 0.20 p = 0.02) asthmatic 
Figure 2. Conditionally reprogramming improves cell population doubling potential. (a) Population doublings 
of healthy AECs (n = 4 patients; CRAEC slope 0.52 ± 0.02; pAEC slope 0.08 ± 0.01; p = 0.0001). (b) Population 
doublings of asthmatic AECs (n = 4 patients; CRAEC slope 0.40 ± 0.03; pAEC slope 0.06 ± 0.02; p = 0.0050). 
(c) Population doublings of CF AEC (n = 4 patients; CRAEC slope 0.50 ± 0.01; pAEC slope 0.06 ± 0.02; 
p = 0.0001). CRAEC ■, pAEC □, ***p < 0.0010, **p < 0.0100.
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(p1: CK5 0.24 ± 0.08 VIM 0.02 ± 0.02 p = 0.01, p5: CK5 0.36 ± 0.22 VIM 0.06 ± 0.05 p = 0.04) and CF (p1: CK5 
0.50 ± 0.17 VIM 0.04 ± 0.04 p = 0.01, p5: CK5 0.86 ± 0.16 VIM 0.12 ± 0.08 p = 0.01).
Gene expression was subsequently validated at the protein level using immunocytochemistry. Staining of 
CRAEC cytospins at both passage 1 and 5 with the sentinel epithelial marker AE1/AE3, displayed very strong 
positive immunostaining that was maintained over passage. This was replicated and observed in all three pheno-
types; healthy (Fig. 5a & b), asthmatic (Fig. 5e & f) and CF (Fig. 5i & j). In contrast, expression of vimentin was 
minimally detected, if at all, in either passage 1 or 5 in any of the three phenotypes assessed; healthy (Fig. 5c & d) 
asthmatic (Fig. 5g & h) and CF (Fig. 5k & l).
Functional differentiation capacity is retained. Airway epithelial cell differentiation. All conditionally 
reprogrammed cultures grown at the ALI stratified into multiple cell layers and differentiated into ciliated and 
mucus-producing cells (Fig. 6a–f). Mucociliary differentiated CRAEC passage one ALI cultures also stained pos-
itively for the typically expressed tight junctional protein, ZO-1 and α-tubulin which stain cilia (Fig. 6a–c). Fixed 
ALI cultures that were sectioned and stained illustrated multiple cell layers and cilia on terminally differentiated 
cells located at the apical surface (Fig. 6d–f). Cryopreserved CRAEC cultures which were thawed, expanded and 
grown at the ALI at passage two and five exhibited similar differentiation capacity (Supplementary Fig. 1a–d).
Figure 3. Cell yield is improved by conditional reprogramming. (a) Cell yield of healthy AECs (CRAEC 
108.2 ± 50.63 thousand cells per cm2, pAEC 28.6 ± 10.54 thousand cells per cm2, p = 0.0001). (b) Cell yield 
of asthmatic AECs (CRAEC 97.8 ± 44.68 thousand cells per cm2 pAEC 33.43 ± 13.36 thousand cells per cm2, 
p = 0.0001) (c) Cell yield of CF AECs (CRAEC 108.1 ± 45.4 thousand cells per cm2, pAEC 36.86 ± 15.97 
thousand cells per cm2, p = 0.0001) CRAEC ■, pAEC □, ***p < 0.0010.
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Figure 4. Gene expression of cytokeratin 19, cytokeratin 5 and vimentin is maintained over passage. (a) Gene 
expression profile of healthy CRAECs from passage one and five. (b) Gene expression profile of asthmatic 
CRAECs from passage one and five. (c) Gene expression profile of CF CRAECs from passage one and five. 
Passage 1 (black bar), passage 5 (open bar). No significant differences between passages or phenotypes. (n = 4 
patients per phenotype/passage, relative expression to housekeeping gene, PPIA).
Figure 5. Expression of the epithelial lineage marker cytokeratin is maintained over passage. Pan-cytokeratin 
antibody (DAKO) (a,b,e,f,i,j), Vimentin antibody (Abcam), (c,d,g,h,k,l), DAPI nuclear stain represented in blue 
on all images. Representative images n = 4 patients per phenotype/passage, Scale bar; 30 µm.
www.nature.com/scientificreports/
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CFTR function. Mucociliary differentiated ALI cultures established from children without CF, both non- cry-
opreserved and cryopreserved cells were observed to retain CFTR function. In the presence of the Na+ channel 
blocker amiloride (Fig. 7a & d; solid line (A)); forskolin stimulated CFTR driven chloride ion secretion was 
shown by an increase in short circuit current (Isc) (Fig. 7a & d; solid line (F)) and this continued to increase with 
the repeated addition of forskolin. In contrast, ALI cultures established from children with CF responded to ami-
loride treatment, as indicated by the drop in Isc (Fig. 7a & d; dotted line (A)). However, cultures did not respond to 
repeated addition of forskolin, indicating a non-functional CFTR (Fig. 7a & d; dotted line (F)) and the retention 
of dysfunctional CFTR. The combined change in Isc for non-cryopreserved healthy CRAECs (30.21 ± 7.36 µA/
cm2) was significantly greater than CF CRAECs (−0.29 ± 0.26 µA/cm2; p = 0.0060) (Fig. 7b). This phenotypic 
functional difference was maintained in cryopreserved cultures at passage two (Fig. 7e) (Heathy 13.54 ± 1.87 µA/
cm2; CF 0.01 ± 0.02 µA/cm2; p = 0.0010). This phenotypic difference was also maintained after cryopreservation 
and five passages (Heathy 8.00 ± 0.95 µA/cm2; CF 0.06 ± 0.08 µA/cm2; p = 0.0010) (Supplementary Fig. 2a & b).
Wound repair. We performed monolayer scratch wound repair experiments as we have previously shown 
this to be defective in pAECs from children with asthma23,24. pAEC wound repair is shown in Fig. 7c (Healthy 
pAECs repaired by 57.00 ± 14.28 hours, asthmatic pAECs at 96 hours post wounding 38.18 ± 14.14% closed) 
to allow direct comparison to the CRAEC wound repair rates. CRAECs derived from both healthy and chil-
dren with asthma, in both non-cryopreserved and cryopreserved CRAECs were wounded and repair mon-
itored. Expectedly, CRAECs from healthy children migrated into the wound site and fully repaired (Fig. 7c 
non-cryopreserved repaired by 45.75 ± 11.32 hours; Fig. 7f cryopreserved repaired by 60.00 ± 12.96 hours; solid 
line). In contrast, CRAECs from children with asthma were unable to fully repair (Fig. 7c; non-cryopreserved 
at 96 hours post wound 35.59 ± 8.08% closed, Fig. 7f cryopreserved at 96 hours post wound 28.97 ± 23.92% 
closed; dashed line). There was no significant difference between the wound repair capacity of pAECs and 
non-cryopreserved CRAECs (Healthy p = 0.2630, Asthmatic p = 0.8680). There was also no significant difference 
between non-cryopreserved CRAECs and cryopreserved CRAECs (Healthy p = 0.1480, Asthmatic p = 0.4320). 
Experiments were also repeated after cryopreservation and extended to passage five with no significant dif-
ferences in repair capacity compared to passage two cryopreserved CRAECs (Healthy p = 0.8939, Asthmatic 
p = 0.3588) (Supplementary Fig. 2c).
Discussion
The study of the airway epithelium has provided important insight regarding the pathobiology of lung diseases 
such as asthma and CF. However, previous limitations of cell yield and expansion capacity of primary cells in 
culture have limited the number of experiments that can be performed from a single sample. This study has 
characterised the lineage and functional capacity of paediatric epithelial cells cultured using a recently developed 
method20 based on co-culture with irradiated NIH-3T3 fibroblast feeders and ROCK inhibitor. Here, condi-
tionally reprogrammed cells maintained a cobblestone morphology over passage independent of phenotype and 
population doublings and cell yields were significantly improved. Epithelial lineage markers were also maintained 
over a set passage length regardless of phenotype and both healthy and diseased CRAECs maintained their abil-
ity to fully differentiate when grown at ALI. Most importantly, we showed that functional characteristics were 
maintained following conditional reprogramming specifically, CFTR function was lacking in CRAECs derived 
from children with CF and defective wound repair was maintained in CRAECs from children with asthma. 
Figure 6. Terminal differentiation at the air-liquid interface (ALI). (a) Differentiation expression profile of 
healthy CRAECs. (b) Differentiation expression profile of asthmatic CRAECs. (c) Differentiation expression 
profile of CF CRAECs. Cilia shown in green, stained using α-tubulin, tight junction protein ZO-1 shown in 
red (oil immersion, Scale bar; 50 µm). (d) Cross section of healthy CRAECs. (e) Cross section of asthmatic 
CRAECs. (f) Cross section of Cystic fibrosis CRAECs. Sections stained with H&E, apical side is the uppermost. 
(Scale bar; 60 µm; representative images, n = 4 patients per phenotype/per passage).
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Collectively, our data demonstrate that conditionally reprogramming of pAEC enables rapid expansion of pri-
mary airway epithelial cells without compromising their lineage characteristics and important disease phenotype 
characteristics. Thus, conditional reprogramming provides a platform, using primary cells that can facilitate the 
Figure 7. Disease specific functional characteristics are maintained in non-cryopreserved and cryopreserved 
CRAECs. (a) Ussing chamber studies utilising differentiated non-cryopreserved ALI cultures from a healthy 
phenotype have functional CFTR (solid line) whereas CF cultures do not (dotted line). Amiloride treatment 
(A) blocks sodium ion adsorption, forskolin treatment (F) stimulates CFTR driven chloride ion secretion. 
Representative tracings of short circuit current (Isc), n = 4 CF patients, n = 4 healthy patients. (b) Change 
in Isc in Ussing chamber studies, after the addition of forskolin in healthy and CF non-cryopreserved ALI 
cultures. Floating bars shown of the min and max with line at the mean, n = 4 CF patients, n = 4 healthy patients 
**p = 0.0060. (c) Asthmatic pAECs and CRAECs have a dysregulated wound repair capacity. Mechanical 
scratch wounds were performed on pAEC (red) and CRAEC (black) submerged monolayer cultures from non-
cryopreserved healthy (solid line & solid squares) and asthmatic children (dashed line & open squares). Wound 
closure was calculated by manual tracing of the new wound area at each time interval, then expressed as a percentage 
of total wound recovery. Both pAECs and CRAECs from asthmatic children (dashed line & open squares) failed 
to repair. (n = 4 healthy patients, asthmatic patients, each performed in technical duplicates at passage two). (d) 
Ussing chamber studies utilising differentiated cryopreserved ALI cultures from a healthy phenotype have functional 
CFTR (solid line) whereas CF cultures do not (dotted line). Amiloride treatment (A) blocks sodium ion adsorption, 
forskolin treatment (F) stimulates CFTR driven chloride ion secretion. Representative tracings of Isc, n = 4 CF 
patients and n = 4 healthy patients. (e) Change in Isc in Ussing chamber studies, after the addition of forskolin in 
healthy and CF cryopreserved ALI cultures. Floating bars shown of the min and max with line at the mean, n = 4 
CF patients, n = 4 healthy patients ***p = 0.0040. (f) Mechanical scratch wounds were performed on CRAEC 
submerged monolayer cultures from cryopreserved healthy (solid line & solid squares) and asthmatic children 
(dashed line & open squares) and wound repair monitored. Cryopreserved asthmatic CRAECs failed to repair. (n = 4 
healthy patients, asthmatic patients, each performed in technical duplicates at passage two).
www.nature.com/scientificreports/
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study of respiratory diseases, where traditionally, tissue has been difficult to access. More importantly, the most 
significant immediate benefit lies with the potential use in personalised therapy particularly in CF. Using CRAECs 
it is now possible to culture sufficient quantities of cells from individuals that can then be used to test the in vitro 
effects of new therapies as they become available and combinations of currently available interventions.
Several papers have begun to characterise the mechanisms that allow cells to be conditionally reprogrammed 
and have shown that it is the combination of ROCK inhibitor and an irradiated fibroblast feeder layer that are 
essential, since individually they appear inefficient at cellular reprogramming20,21,25–27. Mechanistic studies in 
multiple cell types have indicated that reprogramming occurs via modulation of a number of molecular path-
ways, including the suppression of TGF-β and activation of pERK pathways, thus modulating proliferation, 
differentiation and apoptosis, however none have determined the changes, if any over passage from the basal 
phenotype22,25,28. Interestingly Mou et al. used an alternative methodology, namely SMAD signalling inhibition 
to extend the life of basal epithelial cells, however observed that capacity to differentiate at the ALI was lost 
over time29. Our study successfully characterised key markers of epithelial lineage maintenance over passage in 
conditionally reprogrammed primary paediatric airway samples isolated from healthy participants, as well as 
children with mild asthma and children with CF, which are historically more difficult to culture and less readily 
available1,30.
Our data show that the phenotype of CRAEC cultures are maintained over their length in culture (passage 5 
here). Maintenance of epithelial morphology and gene and protein expression profiles indicate that the epithelial 
cells are maintaining their characteristics over passage and not undergoing epithelial-to-mesenchymal transition 
(EMT) where cells appear elongated and spindle-like and change lineage marker expression31,32. Conditional 
reprogramming of pAECs also extends the culture longevity. Here, we limited our characterisation to passage 5, 
where cultures were expanded up to 80 days with significantly higher population doublings compared to pAECs. 
The speed of any population doubling determined in this study were comparable to conditionally reprogrammed 
mammary epithelial cells and epithelium obtained from bronchial biopsy or nasal brushings15,27. In the current 
study, we stopped cultures at passage 5 which gave a potential cell yield of 90 × 1010 cells from 125,000 ex vivo 
cells. CRAECs have however been grown beyond 20 passages in the initial optimisation of this method (data not 
shown). Combined, these improvements produce an approximate 540-fold increase in cells available for research 
purposes after just one passage and one week in culture.
An important and highly relevant aspect of AEC cultures is the ability to differentiate when grown at ALI. This 
model is of emerging importance in asthma research aimed at establishing the effects of pathogens and virus on 
the integrity of epithelial barrier that is inherently leaky in asthmatics33–35. Furthermore, differentiated epithelial 
cultures are the most appropriate model that can be used to study the mechanism of human rhinovirus (HRV)-C 
infection in the airway36–39. Here, we have shown the successful establishment and maintenance of healthy and 
disease AEC grown at ALI. We also provided evidence that all cultures up to passage 5 formed multi-cell layers, 
expressed typical tight junctional proteins and developed cilia. Beyond this, we observed inconsistencies in the 
ability for CRAECs to fully differentiate. Even so, there is a still a significant improvement (132-fold) in the abil-
ity to establish ALIs after just one passage using CRAECs compared to traditional approaches. Collectively, this 
methodology provides an invaluable expansion resource of matched ALI samples typically needed in the devel-
opment of new therapies and interventions that have not previously been possible.
We utilised well differentiated ALI cultures for Ussing chamber studies to show that the functional capacity 
of the ion channels were maintained in non-CF CREACs and defective in CRAECs from children with CF40. 
Depending on their mutation, individuals with CF have differing levels of CFTR function and will respond dif-
ferently to potential therapeutics41,42. Hence, a large culture capacity would be essential when developing and 
screening novel therapeutic interventions or when trialling drug combinations that have the greatest effect 
on improving CFTR function. This is a great advantage over using oncogene-transformed cell lines43 and end 
stage (autopsy or explanted lung)44,45 samples as the results can be applied clinically to a particular patient that 
the epithelial cells were obtained from a few weeks prior. Conditional reprogramming also generates a signifi-
cantly larger number of cells that are mutation and disease specific to an individual that can be cryopreserved. 
This resource has significant future potential in clinically relevant personalised medicine strategies and airway 
mucosal research programs.
The major advantage of the current study and its assessment of CRAECs has been its potential use in research 
programs where primary cell expansion remains a limiting factor. In one such application, we show that CRAECs 
from healthy children retain the ability to close wounds, whereas CRAECs from children with asthma retain a 
defective repair capacity similar to their standard culture counterparts1,23,24. With our reported findings, this 
methodology can now be used to accelerate current efforts to elucidate the mechanism of defective wound repair 
and screen compounds that may restore the reparative capacity in asthmatic patients46. As seen with establishing 
ALI cultures beyond passage 5, we also observed high variability in the reparative capacity of CRAECs within 
phenotypes at extended passage. With the variability observed particularly at extended passage, comprehensive 
validation of any functional analysis that utilises conditional reprogramming is required and that results gener-
ated without this interpreted with potential caution.
The use of CRAECs for potential cellular based therapies may be somewhat more limiting at present, since 
there would be the need to eliminate all animal products from the current methodology to comply with regu-
latory approval. We are currently exploring both substituting the conventional mouse NIH-3T3 that was used 
in this study27,47–50 with a human-derived fibroblast feeder cell layer or removal of the feeder layer entirely. 
Alternative strategies have utilized the feeder layer to generate a conditioned media, bypassing the need for a 
co-culture system. The resulting streamlined methodology was seen to improve population doubling rates com-
pared to non-conditionally reprogrammed cells15. Additional considerations including FCS, ROCK inhibitor 
and cholera toxin that are also present in the F-medium would also need to be substituted or titrated out, as 
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successfully performed by LaRanger and colleagues to recellularize mouse lungs51. Furthermore, karyotype and 
tumourigenicity testing would be required prior to the translation of this technology to therapeutic practice.
In summary, we have described how CRAECs derived from healthy children, as well as those with asthma 
and CF, maintain epithelial lineage marker expression and disease specific functional characteristics. This new 
method allows for fast establishment, expansion and improved longevity of patient specific airway epithelial cell 
cultures. The versatile conditional reprogramming methodology can be used to better understand disease patho-
biology, for high throughput screening in drug discovery pipelines, and for personalised medicine applications.
Materials and Methods
Subjects and primary cell processing. The study was approved by the Princess Margaret Hospital for 
Children and St John of God Hospital Human Ethics Committees and written consent was obtained from each 
participant’s legal guardian after being fully informed about the nature and purpose of the study. All experiments 
were performed in accordance with the relevant committees’ guidelines and regulations. Here, bronchial brush-
ings were obtained from 18 healthy children and 11 children with mild asthma after being admitted into hospital 
for elective non-respiratory related surgery (Table 1). Children with an existing bacterial or viral chest infection 
were excluded. Asthma was defined as physician-diagnosed based upon physician documented wheezing epi-
sodes in the 12-months preceding their recruitment and confirmed by positive responses on the International 
Study of Asthma and Allergies in Children (ISAAC) and American Thoracic Society (ATS) respiratory question-
naires52,53. All children with asthma had mild intermittent disease and had not had received any asthma medi-
cations in the preceding month. Airway brushings were performed as previously described1,10 and ~2.67 × 106 
AEC were obtained from each child10,54. Approximately 5,000 ex vivo epithelial cells per cm2 were then seeded 
into a pre-coated and irradiated fibroblast seeded flask (as described below) to establish a CRAEC culture and 
deemed as passage 0. The remainder of ex vivo cells were used for cytospins, RNA, protein and/or establishing a 
traditional BEGM primary cell culture as previously described1. Children with CF (n = 8) had samples collected 
via bronchoscopy as a component of their annual clinical surveillance program as previously described55. Cystic 
fibrosis transmembrane conductance regulator (CFTR) genotype was determined as part of newborn screening. 
On average, total cell yields were ~1.4 × 106 per child with CF30. Here, 5,000 cells per cm2 were used to establish 
a CRAEC culture as described above, with the remainder used for cytospins, RNA, protein and/or establishing a 
traditional primary cell culture55.
Cell types and medium. NIH-3T3 murine embryonic fibroblasts. NIH-3T3 murine embryonic fibroblasts 
were purchased from the American Type Culture Collection (ATCC) (VA, USA) and maintained in Dulbecco’s 
Modified Eagle Medium (DMEM) growth media (GIBCO, ThermoFisher Scientific Australia) supplemented with 
10% (v/v) foetal calf serum (FCS) and 1% (v/v) penicillin/streptomycin (Life Technologies Australia). All cultures 
were grown at 37 °C in an atmosphere of 5% CO2/95% air under aseptic conditions.
Irradiating fibroblasts. NIH-3T3 fibroblasts were γ-irradiated prior to use in establishing a CRAEC culture. 
Fibroblasts were initially trypsinised and irradiated with 3000 cGy γ-radiation (Gammacell® 3000 Elan; MDS 
Nordion). After γ-irradiation, a total cell count was performed and cells were seeded into a pre-coated tissue 
culture flask at a density of 5,000 cells per cm2 (Corning International) as described20.
F-medium containing ROCK inhibitor. A specialised F-medium was adapted from Liu and colleagues20 for this 
study. This consisted of; 3:1 (v/v) F-12 Nutrient Mixture (Ham) DMEM (Life Technologies Australia), 5% (v/v) 
FCS (Life Technologies Australia), 0.4 µg/mL hydrocortisone, 5 µg/mL insulin, 8.4 ng/mL cholera toxin, 10 ng/mL 
epidermal growth factor, and 24 µg/mL adenine (all Sigma-Aldrich). Finally, 10 µmol/L Y-27632 (ROCK inhibi-
tor) (Enzo Life Sciences) was added to complete the medium.
Bronchial Epithelial Growth Medium. Standard primary AEC (pAEC) cultures were also established and 
expanded in Bronchial Epithelial Basal Medium (BEBM®; LONZA™) supplemented with growth additives and 
2% (v/v) Ultroser G (Pall Corporation) as previously described1,11,23,24. All cultures were grown at 37 °C in an 
atmosphere of 5% CO2/95% air under aseptic conditions.
Primary cell subculture. Passaging of primary CRAEC. All cultures were grown on tissue culture-treated 
plastic flasks pre-coated with extracellular matrix components, fibronectin and type I collagen as described1,11,23,24. 
When CRAEC cultures reached approximately 90% confluence, they were passaged by differential trypsinisation 
using a Trypsin/EDTA reagent pack (LONZA™). This was performed in order to remove feeder cells from the 
Healthy Asthmatic Cystic Fibrosis
Number 18 11 8
Age (years) ± SD 4.7 ± 3.6 4.1 ± 0.9 3.9 ± 2.1
Sex (Male %) 13/18 (72.2) 6/11 (54.5) 4/8 (50)
Hay fever (%) 4/18 (22.2) 4/11 (36.4) n/a
Eczema (%) 5/18 (27.8) 5/11 (45.5) n/a
Phe508del Homozygous (%) n/a n/a 4/8 (50)
Table 1. Patient demographics.
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epithelial culture based on their differential trypsin sensitivity as previously described20. Briefly, growth medium 
was aspirated and cells rinsed with a volume of PBS prior to incubation in Tryspin/EDTA at room temperature 
for 1–2 minutes until fibroblasts had rounded up and lifted off. Cells were rinsed with HEPES-Buffered Saline 
Solution (HBSS), and incubated in an equal volume of Trypsin/EDTA solution at 37 °C for 5–7 minutes or until 
epithelial cells had begun to detach from the tissue culture vessel. Cells were then collected, centrifuged at 500 g 
for 7 minutes at 4 °C, resuspended in F-medium and counted. Viability was also assessed using the trypan-blue 
exclusion method. The appropriate number of CRAEC were then seeded into pre-coated culture vessels1 pre-
seeded with γ-irradiated NIH-3T3 (as described above) to achieve a 1:1 cell ratio and returned to 37 °C in an 
atmosphere of 5% CO2/95% air. Population doubling (PD) was calculated as; PD = 3.32 (log [number of cells 
harvested/number of cells seeded])56. Population doublings were calculated at each passage and shown as accu-
mulative population doublings over days of culture with the line of best fit ± SE indicated. pAEC and CRAEC cul-
tures were then statistically compared using linear regression analysis. Cell yield (CY = cells/cm2) was calculated 
as number of cells harvested x [1 + ((100-% confluence)/100)]/ flask surface area cm2.
Cryopreservation and thawing assessment. CRAECs were cryopreserved after the initial passage in 1 mL of a 
cryopreservation solution containing; 10% (v/v) DMSO (Sigma-Aldrich), 90% (v/v) FCS and 10 µmol/L ROCK 
inhibitor. For thawing assessment, cryopreserved cells were recovered by quick thawing in a 37 °C water bath fol-
lowed by placement into 9 mL of DMEM containing 10% (v/v) FCS (Life Technologies Australia). Cells were then 
centrifuged at 500 g for 7 minutes at 4 °C and resuspended in 1 mL of F-medium after which a total cell count and 
viability were performed. Cells were then seeded into a pre-coated and irradiated NIH-3T3 seeded culture flask 
at a density of 5,000 cells per cm2 in F medium.
Lineage verification. RNA extraction, cDNA synthesis and qPCR. At each passage, 1 million CRAECs were 
collected, pelleted and resuspended in 350 µL RLT buffer containing 1% (v/v) ß-mercaptoethanol (QIAGEN) 
and frozen at −80 °C for downstream analysis. RNA was extracted using the Ambion Purelink® RNA mini kit 
(Thermo Scientific) per manufacturer’s instructions. Genomic DNA was eliminated by on-column RNase-free 
DNase I digestion (QIAGEN) during isolation. RNA purity and quantity was assessed using the Nanodrop 2000 
(Thermo Scientific). Complementary DNA synthesis was carried out as reported previously57 and samples stored 
at −80 °C. Real-time PCR using a SYBR Green protocol1 was used to determine the relative gene expression of 
cytokeratin 5 (CK5), cytokeratin 19 (CK19), vimentin (VIM) and peptidyl-prolyl cis-trans isomerase A (PPIA), 
as outlined in Table 2 57. Relative gene expression was calculated using the 2−ΔΔCT method by normalisation to 
PPIA housekeeping gene and an endogenous tissue control. PPIA was chosen as the housekeeping gene of choice 
due to its uniformity of expression in human epithelial cells derived from healthy and relevant airway disease 
phenotypes57.
Fluorescent immunocytochemistry. Epithelial lineage was confirmed using fluorescent immunocytochem-
istry as previously described1,58. Briefly, fixed cytospun cells were initially rehydrated with 1x PBS and incu-
bated in proteinase K (36 µg/mL; 30 min at 37 °C). Slides were then washed and stained with antibodies specific 
for either epithelial (AE1-AE3 1:250) (DAKO) or mesenchymal cell lineages (Vimentin 1:250) (Abcam), for 
24 hours at 4 °C followed by fluorescently-conjugated secondary antibody (1:1000) (anti-rabbit Alexa Fluor 
488 conjugate; Sigma-Aldrich). Cells were then washed again and counterstained with the nuclear specific 
4′,6-diamidino-2-phenylindole (DAPI) stain (Sigma-Aldrich). Coverslips were then applied using mounting 
media (DAKO) and slides imaged using Nikon® Eclipse Ti inverted microscope (Nikon).
Functional Assays. Airway epithelial cell differentiation. CRAECs utilized in optimization experiments 
were initially seeded on type IV collagen coated Corning® Transwell® 12 mm 0.4 µm pore polycarbonate mem-
brane cell culture inserts (Sigma-Aldrich) at 150,000 cells/insert in complete bronchial air-liquid interface 
(B-ALI®) growth medium (LONZA™) supplemented with 10 µmol/L ROCK inhibitor. Once confluent, growth 
medium was removed from both the apical and basolateral compartments and the insert washed in B-ALI differ-
entiation medium to remove all traces of ROCK inhibitor. B-ALI differentiation medium (LONZA™) was then 
added into the basolateral compartment only and replaced every 48 hours. Cultures were then monitored for the 
development of cilia and mucus via microscopy (Nikon).
Validation experiments incorporating both cryopreserved and non-cryopreserved CRAECs were performed 
using an adapted ALI differentiation media as previously described59–61. Briefly, media consisted of a 1:1 mixture 
Gene Primer Sequence Product Length (bp)
Cytokeratin 5 (CK5)
Forward 3′-TGGAGATCGCCACTTACCG-5′
109
Reverse 5′-CCAGAGGAAACACTGCTTGTG-3′
Cytokeratin 19 (CK19)
Forward 3′-CAGCTTCTGAGACCAGGGTT-5′
70
Reverse 5′-GACTGGCGATAGCTGTAGGA-3′
Vimentin (VIM)
Forward 3′-GAGGAGATGCGGGAGCTG-5′
95
Reverse 5′-ATGATGTCCTCGGCCAGGTT-3′
Peptidyl-prolyl cis-trans 
isomerase A (PPIA)
Forward 3′-CCTTGGGCCGCGTCTCCTTT-5′
307
Reverse 5′-CACCACCCTGACACATAAACCCTGG-3′
Table 2. Oligonucleotide Primers.
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of 1xLHC medium and Dulbecco’s Modified Eagle’s Media (DMEM; GIBCO) supplemented with bovine pitui-
tary extract (BPE, 10 μg/ml), hydrocortisone (0.21 μM), human epidermal growth factor (hEGF; 0.5 ng/ml), (L)
epinephrine (2.7 μM), insulin (0.87 μM), triiodothyronine (0.01 μM), holotransferrin (0.125 μM), penicillin-G 
sodium (100 U/ml), streptomycin sulfate (100 μg/ml), bovine serum albumin (0.5 mg/ml), trans-retinoic 
acid (50 nM), phosphorylethanolamine (0.5 μM), ethanolamine (0.5 μM), zinc sulfate (3 μM), iron (II) sulfate 
(1.5 μM), magnesium chloride hexahydrate (0.6 mM), calcium chloride dihydrate (1 mM), selenium (30 nM), 
manganese (1 nM), silicone (500 nM), molybdenum (1 nM), vanadium (5 nM), nickel (1 nM) and tin (0.5 nM) 
(all Sigma-Aldrich)59. CRAECs were seeded on type IV collagen coated Corning® Transwell® 12 mm 0.4 µm pore 
polycarbonate membrane cell culture inserts (Sigma-Aldrich) at 150,000 cells/insert in ALI59–61 medium supple-
mented with 10 µmol/L ROCK inhibitor. Once confluent, medium was removed from both the apical and baso-
lateral compartments and the insert washed in DMEM to remove all traces of ROCK inhibitor. ALI medium was 
then added into the basolateral compartment only and replaced every 48 hours. Cultures were then monitored for 
the development of cilia and mucus via microscopy (Nikon).
Once CRAEC ALI cultures achieved differentiation, they were fixed in ice cold 100% methanol for 10 minutes 
for antibody staining or Carnoy’s fixative for sectioning. Methanol fixation was followed by a PBS wash at room 
temperature (RT), and stored at 4 °C in fresh 1 x PBS until stained. Cilia were visualised using α-tubulin (1:300; 
Sigma-Aldrich clone DM1A), tight junction protein ZO-1 (1:100; 2.5 µg/mL; Life Technologies Australia Clone: 
ZO1-1A12) and nuclei stain Hoechst 33342 (2.5 μg/mL; Sigma-Aldrich). Secondary antibodies used included; 
AlexaFluor 488 (1:200; 10 µg/mL; Goat anti-Mouse and Goat anti-Rabbit) and AlexaFluor 568 (1:200; 10 µg/mL; 
Goat anti-Mouse and Goat anti-Rabbit) (Life Technologies Australia). A Nikon A1 inverted confocal microscope, 
with a Nikon Plan Apo VC 60x NA 1.4 oil immersion objective and NIS-AR Elements software (v4.2.22, Nikon) 
was used for imaging. Z-stack images with step size of 0.5 µm were collected with a pinhole of 35.8 µm (1.2 A.U. 
for 488 nm laser), where the top and bottom of the stacks were determined visually.
CRAEC ALI cultures used for sectioning were fixed in Carnoy’s fixative solution (60% ethanol, 30% chlo-
roform and 10% glacial acetic acid) for 24 hours, rinsed in PBS and then stored at 4 °C in 100% ethanol. Inserts 
were removed from fixative and placed on a foam pad in a standard histology cassette. After overnight dehy-
dration paraffin infiltration was done using a Leica tissue processor. Inserts were embedded upright for vertical 
cross-sectioning to show cell layers. After processing, specimens placed into embedding station wax bath. 5um 
sections were cut and allowed to bake overnight at 60 °C after which they were stained with Hematoxylin and 
Eosin (H&E) using a Leica Autostainer. An Olympus BX53 microscope was used to visualise the sections.
CFTR function. Differentiated CRAEC ALI cultures derived from children with and without CF were estab-
lished at passage 2 and 5 for chloride ion transport studies using Ussing chamber (Physiologic Instruments Inc.). 
A chloride ion gradient was established by filling the basolateral compartment with Krebs Ringer bicarbonate 
solution as previously described62. Amiloride (Sigma-Aldrich) was added to the mucosal compartment to a final 
concentration of 50 µM to block sodium absorption followed by the stepwise addition of mucosal forskolin to a 
concentration of 0.2–20 µM (F6886 Sigma-Aldrich) to stimulate CFTR-mediated chloride ion secretion.
Wound repair assay. Passage 2 pAECs, passage 2 and passage 5 CRAECs were seeded into 12 well plates at a 
density of 200,000 cells per well in BEBM with SingleQuot supplements (LONZA™), minus epidermal growth 
factor (EGF) based on previous wound repair assays23,24,63. Cells were grown to form a 100% confluent monolayer. 
To assess wound repair kinetics, a single linear wound was created using a plastic P200 pipette tip (0.5 mm wound 
width) and time lapse images taken using an IncuCyte ZOOM™ System (Essen BioScience). Wound closure was 
then calculated as previously described23,24,63.
Statistical Analysis. Experiments were performed in at least duplicate, with a minimum of 4 patients per exper-
imental cohort. Data are presented as means (±SD) where applicable. Linear regression analysis was used to 
compare lines of best fit for population doublings and non-parametric Wilcoxon match pairs signed rank tests 
were used to compare statistical significance between passages. P values less than 0.05 (*), 0.01 (**) and 0.001 
(***) were reported in this study to indicate the extent of statistical significance.
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